Morgan Stanley Favors GoodRx (GDRX) and Healthcare Tech Over Managed Care for 2026 Citing Strong Market-Beating Potential

GoodRx Holdings Inc. (NASDAQ:GDRX) is one of the cheap penny stocks to invest in. On December 18, Morgan Stanley lowered the firm’s price target on GoodRx to $4 from $5 and kept an Equal Weight rating on the shares. In a 2026 outlook for the Healthcare Services sector, the firm highlighted a strong environment for market-beating returns within healthcare tech and provider stocks. In contrast, Morgan Stanley remains cautious on managed care and noted that after a weak 2025, the subsector continues to face a ...